Schroder Investment Management Group’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-29,652
| Closed | -$654K | – | 1151 |
|
|
2016
Q2 | $654K | Sell |
29,652
-12,164
| -29% | -$268K | ﹤0.01% | 951 |
|
|
2016
Q1 | $1.19M | Sell |
41,816
-397,487
| -90% | -$11.3M | ﹤0.01% | 894 |
|
|
2015
Q4 | $14.5M | Buy |
439,303
+210,303
| +92% | +$6.94M | 0.03% | 548 |
|
|
2015
Q3 | $8.28M | Sell |
229,000
-24,278
| -10% | -$878K | 0.02% | 641 |
|
|
2015
Q2 | $11M | Buy |
253,278
+239,500
| +1,738% | +$10.4M | 0.02% | 616 |
|
|
2015
Q1 | $432K | Buy |
+13,778
| New | +$432K | ﹤0.01% | 1013 |
|